• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

The screen interval for high cardiovascular disease risk should be individual

Bioengineer by Bioengineer
April 3, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Current American Heart Association, European Society of Cardiology, and UK National Health Service guidelines recommend a 5-yearly health check interval for screening of individuals at high cardiovascular disease risk. This health check covers measurement of a variety of risk factors including systolic blood pressure, cholesterol profile, blood glucose, and smoking status.

If lifestyle interventions are inadequate to reduce the risk, the guidelines recommend primary preventive medication such as statins. However, the 5-yearly screenings are not based on direct research evidence.

According to a study published today in The Lancet Public Health, screening for high cardiovascular disease risk should be based on individual risk level. The authors conclude that this would be achieved without increased health care costs. The study showed that current 5-year screening intervals were unnecessarily frequent for low-risk individuals and insufficiently frequent for intermediate-risk individuals.

“Our study shows that by optimizing the screening intervals, 8% of myocardial infarcts and strokes could be prevented without increase in health care costs. This means that during the next 20 years, in the English population aged now 40 to 64, the number of new myocardial infarcts or strokes prevented annually could reach 5000,” says lead author Joni Lindbohm MD, PhD from the University of Helsinki.

The authors estimated the optimal screening interval by following development of cardiovascular disease risk in 7000 English men and women who participated in the Whitehall II study. This study measured their cardiovascular disease risk factors according to the current guidelines in 5-yearly intervals over a 22-year follow-up and collected data on cardiovascular diseases using national electronic health and death records.

Those at low risk for cardiovascular diseases spent on average 9 years in that risk category before moving to intermediate-low risk. The participants then spent on average 7 years in this next category before progressing to intermediate-high risk. However, the time spent in intermediate-high risk was only 4 years; after this, over 70% of participants progressed to the high-risk category that leads to consideration of preventive medication if lifestyle intervention is insufficient to reduce the risk.

An individualized screening interval would enable more effective cardiovascular disease prevention by means of lifestyle intervention or preventive medication, because of more timely detection of those at high risk.

“The results are promising, but national guidelines are rarely changed based on one study. The benefits of individualized screening intervals should be further studied in a randomized control trial before changing the guidelines emphasizes one of the authors, Professor Mika Kivimäki, Director of the Whitehall II study at University College London.

###

Media Contact
Joni Lindbohm
joni.lindbohm@helsinki.fi
https://www.helsinki.fi/en/news/health-news/the-screen-interval-for-high-cardiovascular-disease-risk-should-be-individual

Tags: CardiologyCholesterolDiabetesHealth Care Systems/ServicesMedicine/HealthMetabolism/Metabolic DiseasesPublic HealthStroke
Share12Tweet8Share2ShareShareShare2

Related Posts

Experienced Pathologists Vary in Dissection Plane Assessments After Transanal Mesorectal Excision

Experienced Pathologists Vary in Dissection Plane Assessments After Transanal Mesorectal Excision

November 19, 2026
Clinical Review Evaluates Cannabidiol Efficacy, Molecular Targets, and Commercial Safety Risks

Clinical Review Evaluates Cannabidiol Efficacy, Molecular Targets, and Commercial Safety Risks

November 19, 2026

Cochrane Review Finds Turmeric Supplements Offer Little Relief for Knee Osteoarthritis

November 19, 2026

Moderate Hyperlactataemia After Paediatric Brain Tumour Surgery Shows No Link to Mortality

November 19, 2026
Please login to join discussion

POPULAR NEWS

  • Dyspnea and Eco-Anxiety Independently Link to Poorer Quality of Life in COPD

    Dyspnea and Eco-Anxiety Independently Link to Poorer Quality of Life in COPD

    29 shares
    Share 12 Tweet 7
  • Dystrophic Epidermolysis Bullosa Patients in Poland Face High Mental Health Morbidity

    29 shares
    Share 12 Tweet 7
  • Machine Learning Predicts Liver Fibrosis Risk in Prior Schistosoma Japonicum Infection

    29 shares
    Share 12 Tweet 7
  • Israeli Policy and Nursing Perspectives Diverge on Second Victim Phenomenon

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Experienced Pathologists Vary in Dissection Plane Assessments After Transanal Mesorectal Excision

Electrospun Cyclodextrin Nanofibers Deliver Flavonoid Antioxidants and Extend Strawberry Freshness

Purified Tremella Polysaccharide Fraction Boosts Stability of Curcumin-Loaded Zein Nanoparticles

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.